• 117. Meningococcal Vaccine: Prevention of Meningococcal Disease in Adolescents and Young Adults

  • Jun 26 2024
  • Duración: 53 m
  • Podcast

117. Meningococcal Vaccine: Prevention of Meningococcal Disease in Adolescents and Young Adults  Por  arte de portada

117. Meningococcal Vaccine: Prevention of Meningococcal Disease in Adolescents and Young Adults

  • Resumen

  • On this episode of NP Pulse: The Voice of the Nurse Practitioner®, Drs. Mary Koslap-Petraco and Ruth Carrico will discuss meningococcal disease, the maze of meningococcal vaccines, ACIP recommendations and the use of shared clinical decision-making. Meningococcal disease — a life-threatening infection caused by Neisseria meningitidis — demands our attention. It strikes swiftly, leaving devastation in its wake. Still, we have powerful tools at our disposal: MenACWY and MenB vaccines, and a new, game-changing pentavalent vaccine that covers serogroups A, B, C, W and Y. Additionally, a meningitis point-of-care tool will be available on AANP’s Tools and Resources page.

    To earn 1.0 contact hours of continuing education (CE) credit, you will need the participation code provided at the end of the podcast. To claim your CE credit, log in and register for the activity within the AANP CE Center, then enter the participation code and complete the post-test and evaluation. CE credit is available for this podcast through June 2025.

    This educational activity is supported by an independent medical education grant from GSK.

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre 117. Meningococcal Vaccine: Prevention of Meningococcal Disease in Adolescents and Young Adults

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.